# Metabolic Effects of Natriuretic Peptide Hormones

> **NCT03397966** · PHASE4 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 5 (actual)

## Conditions studied

- Obesity
- Cardiovascular Physiological Phenomena
- Metabolism

## Interventions

- **DRUG:** recombinant human BNP(1-32)
- **DRUG:** placebo (control, normal saline)

## Key facts

- **NCT ID:** NCT03397966
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Study drug no longer available
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397966, "Metabolic Effects of Natriuretic Peptide Hormones". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03397966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*